ArticleSignal transduction and targeted therapy2025
Rapavir, a novel inhibitor of sodium taurocholate cotransporting polypeptide, potently blocks hepatitis B virus entry.
Jia He, Haibo Yu, Kunling Song, Ailong Huang, Yongjun Dang, Juan Chen, Zufeng Guo
Abstract readLetter
In one paragraphArticle in Signal transduction and targeted therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Jia He *Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention (Ministry of Education), College of Pharmacy & Department of Breast and Thyroid Surgery of the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Haibo Yu *Institute for Viral Hepatitis, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Kunling Song *Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention (Ministry of Education), College of Pharmacy & Department of Breast and Thyroid Surgery of the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ailong HuangInstitute for Viral Hepatitis, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.ORCID http://orcid.org/0000-0003-0148-7423 Yongjun DangBasic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention (Ministry of Education), College of Pharmacy & Department of Breast and Thyroid Surgery of the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. yjdang@cqmu.edu.cn.
Juan ChenInstitute for Viral Hepatitis, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. chenjuan2014@cqmu.edu.cn.
Zufeng GuoBasic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention (Ministry of Education), College of Pharmacy & Department of Breast and Thyroid Surgery of the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. zfguo@cqmu.edu.cn.ORCID http://orcid.org/0000-0002-4370-9445 Funding
China Postdoctoral Science Foundation 2020M683638XBChina Postdoctoral Science Foundation 2021T140784Chongqing Postdoctoral Science Foundation CSTB2022NSCQ-BHX0616National Natural Science Foundation of China (National Science Foundation of China) 22137002National Natural Science Foundation of China (National Science Foundation of China) 22277010National Natural Science Foundation of China (National Science Foundation of China) 22477013National Natural Science Foundation of China (National Science Foundation of China) 82273423National Natural Science Foundation of China (National Science Foundation of China) 82302507National Natural Science Foundation of China (National Science Foundation of China) 92353303National Natural Science Foundation of China (National Science Foundation of China) U23A20472Natural Science Foundation of Chongqing (Natural Science Foundation of Chongqing Municipality) CSTB2022NSCQ-MSX1061
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40263266
PMCPMC12015363
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390